๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

ALIMTATM in combination with carboplatin demonstrates clinical activity against malignant mesothelioma in a phase I trial

โœ Scribed by Calvert, A; Hughes, A.N; Calvert, P.M; Plummer, R.E; Highley, M.S

Book ID
118569604
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
205 KB
Volume
29
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Gemcitabine combined with carboplatin in
Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma : A multicentric Phase II study
โœ Adolfo G. Favaretto; Savina M. L. Aversa; Adriano Paccagnella; Vincenzo De Pangh ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 90 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND Malignant pleural mesothelioma (MPM) is increasing rapidly worldwide. Currently, pemetrexed plus cisplatin chemotherapy showed a survival advantage versus cisplatin alone. No impact on patient survival of surgery, radiotherapy, or their combination has been demonstrated.